Vancouver, BC – Genome BC has named Pascal Spothelfer as its new president & chief executive officer beginning Monday, June 6.
Dr. Spothelfer joins Genome BC with a great deal of business and commercialization experience. His past work has included time as a management consultant with the Boston Consulting Group and as an executive of Jenoptik AG in Germany. After four years as president and CEO of NovAtel Inc. in Calgary, he moved to Vancouver where he became president and CEO of Spectrum Signal Processing, spent three years at the helm of the BC Technology Industry Association (BCTIA) and worked as vice president communications and community partnerships at the University of British Columbia.
“With his proven track record, I am confident he will provide the leadership and vision necessary to further enhance Genome BC’s position as a key driver of BC’s bioeconomy; optimizing impact for all British Columbians,” said Dr. Ian de la Roche, chairman, Board of Directors, Genome BC. “Pascal’s extensive experience and significant success in leading strategic innovation and change will help to strengthen Genome BC’s already strong track record.”
Dr. Spothelfer holds a law degree and a PhD in Law from the University of Basel in Switzerland and a MBA from INSEAD in Fontainebleau, France. He replaces Dr. Alan Winter who recently announced his retirement after 14 years at the helm of Genome BC.
“I would also like to recognize the invaluable contribution of Dr. Alan Winter,” said Dr. de la Roche. “Alan’s leadership and strategic vision have positioned both the organization and province as a genomics power house in Canada. The strong government and community support experienced by the organization is a true testament to Alan’s character and expertise.”